Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples